The level of Ig anti-RBD SARS-CoV-2 after two doses of CoronaVac vaccine
J Med Virol
.
2022 Mar;94(3):829-832.
doi: 10.1002/jmv.27390.
Epub 2021 Oct 18.
Authors
Zulvikar S Ulhaq
1
,
Gita V Soraya
2
,
Kristin Indriana
3
,
Rizky Devitasari
4
,
I Putu Yupindra Pradiptha
5
,
Dilloniar B Zulfikar
6
,
Vita Uxiana
7
,
Zulkarnain
8
,
Lailia N Rachma
1
,
Ditya Arisanti
1
Affiliations
1
Faculty of Medicine and Health Science, Maulana Malik Ibrahim State Islamic University of Malang, Malang, East Java, Indonesia.
2
Faculty of Medicine, Hasanuddin University, Makassar, South Sulawesi, Indonesia.
3
Kanjuruhan Hospital, Malang, East Java, Indonesia.
4
Faculty of Medicine, Brawijaya University, Malang, East Java, Indonesia.
5
Utama Sari Dharma Hospital, Bali, Indonesia.
6
Premier Hospital, Surabaya, East Java, Indonesia.
7
Almiraskin Clinic, Samarinda, East Borneo, Indonesia.
8
Faculty of Medicine, Syiah Kuala University, Banda Aceh, Aceh, Indonesia.
PMID:
34647630
PMCID:
PMC8661683
DOI:
10.1002/jmv.27390
No abstract available
Keywords:
COVID-19; CoronaVac vaccine; Ig anti-RBD; SARS-CoV-2; antibody titers.
Publication types
Letter
MeSH terms
COVID-19 Vaccines
COVID-19* / prevention & control
Humans
SARS-CoV-2
Vaccines*
Substances
COVID-19 Vaccines
Vaccines